• Analytical Science and Technology
• /
• v.13 no.1
• /
• pp.22-26
• /
• 2000

2-Hydroxybenzaldehyde-5-Nitro-pyridylhydrazone (2HB-5NPH) was synthesized and its application in the spectrophotometric determination of vanadium ion(IV) was studied in the presence of surfactant. The optimum conditions of pH, solvent effect, concentration of ligand and surfactant were evaluated. The procedure was applied to determination of vanadium (IV) in mixture sample and real sample with satisfactory results (recovery ${\geq}$ 97% ; relative standard deviation ${\leq}$ 3.0% in the concentration range of $0{\sim}1.5{\mu}g/mL$ ; detection limit, $0.02{\mu}g/mL$ in solution).

• Journal of the Korean Chemical Society
• /
• v.43 no.5
• /
• pp.522-526
• /
• 1999

2-Hydroxybenzaldehyde-5-nitro-pyridylhydrazone (2HB-5NPH) was synthesized and its application to the spectrophotometric determination of iron was studied. The reagent reacts with iron in the pH range 6.0-7.5 to form a yellow coIored 1:2 chelate which is very stable in methanol solution. Beer's law is obeyed in the concentration range 0.05∼2.0 ${\mu}gmL^{-1}$ iron and separation procedure using a short column filled with Amberlite XAD-7 nonionic chelating resin is proposed for the spectrophotometric determination of traces of iron. The influence of several ions as interference was discussed. The separation of Fe(III) ion from the mix-ture solution were carried out with the buffer solution (pH 5.0) and 0.25M HCl as eluents.

• Clinical and Experimental Pediatrics
• /
• v.50 no.6
• /
• pp.565-569
• /
• 2007

Purpose : With a duration of action of approximately 24 hours and peakless levels, Lantus is a more physiologic basal insulin analogue compared with NPH. The aim of this study was to compare the glycemic control of Lantus plus Humalog with that of premixed insulin in children and adolescents with type 1 diabetes mellitus. Methods : The subjects consisted of 25 patients with type 1 diabetes mellitus, aged 12-19 years, who changed their insulin regimen from premixed insulin to Lantus plus Humalog. Daily insulin doses, frequency of hypoglycemia, fasting blood glucose, C-peptide concentration and HbA1c before and 6 months after Lantus treatment were compared. 24 hour blood glucose of 11 patients among Lantus treatment group (n=25) and premixed insulin treatment group (n=10) were self-monitored and compared. Results : 6 months after Lantus treatment, the episodes of hypoglycemia were reduced by 50%(15.1 vs. 7.6 events/month), especially nocturnal hypoglycemia by 67%(6.7 vs. 2.5 events/month). HbA1c was reduced from 9.3% to 8.7% after Lantus treatment. Self-monitored blood glucose of Lantus treatment group at postbreakfast 30, 60, 90 and 120 minutes were 171.1, 169.5, 171.0 and 154.1 mg/dL respectively and lower than those of premixed insulin treatment group (259.7, 282.7, 280.0 and 250.9 mg/dL respectively). Conclusion : Compared with premixed insulin, Lantus plus Humalog is more effective in glycemic control and reduction in nocturnal hypoglycemia in children and adolescents with type 1 diabetes mellitus.